Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 21.50B INR in the quarter ending June 30, 2026, with 25.66% growth. This brings the company's total for the last twelve months to 77.84B, up 14.12% year-over-year. In the fiscal year ending March 31, 2026, Alembic Pharmaceuticals had annual revenue of 73.45B with 10.08% growth. That makes Alembic Pharmaceuticals the 8,561st largest company in the world by revenue and 326th in India.

• Revenue (ttm): 77.84B
• Revenue Growth: +14.12%
• P/S Ratio: 1.97
• Revenue / Employee: 4.51M
• Employees: 17,244
• Market Cap: 149.44B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Outside India 46.00B 62.6%
• India 27.45B 37.4%

Fiscal year ended Mar 31, 2026 See the full Alembic Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	73.45B	6.73B	10.08%
Mar 31, 2025	66.72B	4.43B	7.12%
Mar 31, 2024	62.29B	5.76B	10.19%
Mar 31, 2023	56.53B	3.47B	6.54%
Mar 31, 2022	53.06B	-873.40M	-1.62%

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error